CARMIEL, Israel , Sept. 4, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX),

Company is debt-free with no outstanding notes Balance sheet provides sufficient runway for ongoing operations

Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel , Aug. 14, 2024 /PRNewswire